RT Journal Article
SR Electronic
T1 ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e000673
DO 10.1136/jitc-2020-000673
VO 8
IS 1
A1 Lopes, Jared E
A1 Fisher, Jan L
A1 Flick, Heather L
A1 Wang, Chunhua
A1 Sun, Lei
A1 Ernstoff, Marc S
A1 Alvarez, Juan C
A1 Losey, Heather C
YR 2020
UL http://jitc.bmj.com/content/8/1/e000673.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.